D-0759-2026 Class II Ongoing

Recalled by Shoolin Pharma Chem LLP — Kadi

FDA drug recall D-0759-2026 was initiated by Shoolin Pharma Chem LLP on Aug 3, 2026 and is designated Class II. Reason for recall: CGMP Deviations:Noted during FDA inspection The recall status is ongoing. Affected quantity: 25KG, 250-1gm bags.

Recall details

Product Type
Drugs
Report Date
Aug 19, 2026
Initiation Date
Aug 3, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
25KG, 250-1gm bags

Product description

SILDENAFIL CITRATE USP, 0.100 KG, 100 gm-bag Net Wt, RX ONLY "FOR Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesana, Gujarat, 382715, India, (CAS NO. 171599-83-0) NDC 85702-001-05

Reason for recall

CGMP Deviations:Noted during FDA inspection

Distribution pattern

Distributed Nationwide in the USA

Code information

Batch SDC2505001, Date of Expiry: April 30, 2030.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0759-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0759-2026. Report a data issue: hello@regdatalab.com.